X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/exithera-pharmaceuticals-announces-fda-acceptance-of-ind-application-for-phase-2-trial-of-ep-7041-for-thrombosis-prevention-in-covid-19-patients-301239411.html